Company Filing History:

6 out of 1,451

Sanofi

Societe Anonyme Sanofi

patents

Years Active: 1986-2002

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6380230 - Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them (2002-04-30),

2. 5656648 - Polysubstituted 2-amino-thiazole derivatives (1997-08-12),

3. 5656631 - Pyridazine derivatives (1997-08-12),

4. 5631255 - Pyridazine derivatives (1997-05-20),

5. 5461053 - Pyridazine derivatives (1995-10-24),

6. 5380736 - Heterocyclic substituted 2-acylamino-5-thiazoles, their preparation and (1995-01-10),

7. 5314889 - Heterocyclic substituted 2-acylamino-5-thiazoles, their preparation and (1994-05-24),

8. 5086053 - Derivatives of 1,3,4-thiadiazole, a method of obtaining them and (1992-02-04),

9. 4983603 - Tricyclic cholinergic receptor agonists (1991-01-08),

10. 4596802 - Thiadiazole derivatives active on the central nervous system and (1986-06-24),

Title: The Innovative Mind of Roger Brodin: A Journey through Patents and Collaborations

Introduction: Roger Brodin, located in Montpellier, France, is an accomplished inventor with a remarkable portfolio of ten patents to his name. His work primarily revolves around the development of pharmaceutical compounds, demonstrating a commitment to advancing medical science and improving health outcomes.

Latest Patents: Among his notable inventions are the "Carboxamidothiazole derivatives, preparation, pharmaceutical compositions containing them" and various "Pyridazine derivatives." These pyridazine derivatives are particularly significant, as they are described as valuable ligands for cholinergic receptors, especially the M1 type, highlighting their potential therapeutic applications.

Career Highlights: Roger Brodin has had a substantial influence on the pharmaceutical industry through his innovative contributions. He has worked at prestigious companies, including Sanofi and Elf Sanofi, where he focused on research and development initiatives that push the boundaries of pharmacology.

Collaborations: Throughout his career, Brodin has collaborated with esteemed colleagues such as Dominique Olliero and Robert Boigegrain. These partnerships have fostered an environment of creativity and innovation, leading to several groundbreaking developments in pharmaceutical research.

Conclusion: Roger Brodin's journey as an inventor in Montpellier portrays a dedicated contributor to the field of pharmaceutical sciences. With his impressive array of patents and collaborative efforts, he continues to make strides that could potentially revolutionize treatments and enhance our understanding of complex medical conditions. His work serves as an inspiration for budding inventors and professionals in the industry.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.